Experts Urge Routine Test for All Patients With Invasive Breast Cancer

Standardized HER2 screen would help ensure women get appropriate therapy, guideline authors say

HealthDay SHARE

Guideline panelist Hammond added that women who are newly diagnosed with invasive breast cancer should ask if the medical center where they're receiving testing and treatment is following the ASCO/CAP guidelines. "If I were a patient with breast cancer, I would want to make sure that my tissue sample was examined by a facility that's following the guidelines," Hammond said.

The new guidelines were released online Oct. 7 in the Journal of Clinical Oncology and also appear in the Archives of Pathology & Laboratory Medicine.

More information

Learn more about HER2 testing and breast cancer treatments from the U.S. National Cancer Institute.

Copyright © 2012 HealthDay. All rights reserved.